Bill
HB 1139
allow individualized investigative treatments for patients with life-threatening or debilitating diseases or conditions.
2025 Regular Session
Introduced by Bobbi Andera and 9 co-sponsors
South Dakota allows terminally ill patients access to investigational treatments not yet approved by the FDA, enabling compassionate use outside standard trial requirements.
Signed by the Governor on 2025-03-31 H.J. 554